Quality of life and functional outcomes after laparoscopic total mesorectal excision (LaTME) and transanal total mesorectal excision (taTME) for rectal cancer. an updated meta-analysis.
Functional outcomes
Laparoscopic TME
Meta-analysis
Quality of Life
Rectal cancer
Transanal TME
Journal
International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899
Informations de publication
Date de publication:
09 Aug 2024
09 Aug 2024
Historique:
accepted:
02
08
2024
medline:
9
8
2024
pubmed:
9
8
2024
entrez:
9
8
2024
Statut:
epublish
Résumé
Concerns exist regarding the potential for transanal total mesorectal excision (TaTME) to yield poorer functional outcomes compared to laparoscopic TME (LaTME). The aim of this study is to assess the functional outcomes following taTME and LaTME, focusing on bowel, anorectal, and urogenital disorders and their impact on the patient's QoL. A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and A Measurement Tool to Assess systematic Reviews (AMSTAR) guidelines. A comprehensive search was conducted in Medline, Embase, Scopus, and Cochrane Library databases. The variables considered are: Low Anterior Resection Syndrome (LARS), International Prostate Symptom Score (IPSS) and Jorge-Wexner scales; European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C29 and QLQ-C30 scales. Eleven studies involving 1020 patients (497-taTME group/ 523-LaTME group) were included. There was no significant difference between the treatments in terms of anorectal function: LARS (MD: 2.81, 95% CI: - 2.45-8.08, p = 0.3; I2 = 97%); Jorge-Wexner scale (MD: -1.3, 95% CI: -3.22-0.62, p = 0.19). EORTC QLQ C30/29 scores were similar between the groups. No significant differences were reported in terms of urogenital function: IPSS (MD: 0.0, 95% CI: - 1.49-1.49, p = 0.99; I This review supports previous findings indicating that functional outcomes and QoL are similar for rectal cancer patients who underwent taTME or LaTME. Further research is needed to confirm these findings and understand the long-term impact of the functional sequelae of these surgical approaches.
Identifiants
pubmed: 39120642
doi: 10.1007/s00384-024-04703-x
pii: 10.1007/s00384-024-04703-x
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
129Informations de copyright
© 2024. The Author(s).
Références
You YN, Hardiman KM, Bafford A, Poylin V, Francone TD, Davis K, Paquette IM, Steele SR, Feingold DL (2020) The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer. Dis Colon Rectum 63:1191–1222. https://doi.org/10.1097/DCR.0000000000001762
doi: 10.1097/DCR.0000000000001762
pubmed: 33216491
Penna M, Buchs NC, Bloemendaal AL, Hompes R (2016) Transanal Total Mesorectal Excision for Rectal Cancer: The Journey towards a New Technique and Its Current Status. Expert Rev Anticancer Ther 16:1145–1153. https://doi.org/10.1080/14737140.2016.1240040
doi: 10.1080/14737140.2016.1240040
pubmed: 27690685
Sylla P, Rattner DW, Delgado S, Lacy AM (2010) NOTES Transanal Rectal Cancer Resection Using Transanal Endoscopic Microsurgery and Laparoscopic Assistance. Surg Endosc 24:1205–1210. https://doi.org/10.1007/s00464-010-0965-6
doi: 10.1007/s00464-010-0965-6
pubmed: 20186432
Vignali A, Elmore U, Milone M, Rosati R (2019) Transanal Total Mesorectal Excision (TaTME): Current Status and Future Perspectives. Updat Surg 71:29–37. https://doi.org/10.1007/s13304-019-00630-7
doi: 10.1007/s13304-019-00630-7
Gloor S, Pozza G, Troller R, Wehrli M, Adamina M (2023) Surgical Outcomes, Long-Term Recurrence Rate, and Resource Utilization in a Prospective Cohort of 165 Patients Treated by Transanal Total Mesorectal Excision for Distal Rectal Cancer. Cancers 15:1190. https://doi.org/10.3390/cancers15041190
doi: 10.3390/cancers15041190
pubmed: 36831531
pmcid: 9954312
Ng JY, Chen C-C (2022) Transanal Total Mesorectal Excision for Rectal Cancer: It’s Come a Long Way and Here to Stay. Ann Coloproctology 38:283–289. https://doi.org/10.3393/ac.2022.00374.0053
doi: 10.3393/ac.2022.00374.0053
Emile SH, Lacy FBD, Keller DS, Martin-Perez B, Alrawi S, Lacy AM, Chand M (2018) Evolution of Transanal Total Mesorectal Excision for Rectal Cancer: From Top to Bottom. World J Gastrointest Surg 10:28–39. https://doi.org/10.4240/wjgs.v10.i3.28
doi: 10.4240/wjgs.v10.i3.28
pubmed: 29588809
pmcid: 5867456
Jiang T, Ma J, Zheng M (2021) Controversies and Consensus in Transanal Total Mesorectal Excision (taTME): Is It a Valid Choice for Rectal Cancer? J Surg Oncol 123:S59–S64
doi: 10.1002/jso.26340
pubmed: 33650698
Yi Chi Z, Gang O, Xiao Li F, Ya L, Zhijun Z, Yong Gang D, Dan R, Xin L et al (2024) Laparoscopic Total Mesorectal Excision versus Transanal Total Mesorectal Excision for Mid and Low Rectal Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 103:e36859. https://doi.org/10.1097/MD.0000000000036859
doi: 10.1097/MD.0000000000036859
pubmed: 38277570
Aubert M, Mege D, Panis Y (2020) Total Mesorectal Excision for Low and Middle Rectal Cancer: Laparoscopic versus Transanal Approach—a Meta-Analysis. Surg Endosc 34:3908–3919. https://doi.org/10.1007/s00464-019-07160-8
doi: 10.1007/s00464-019-07160-8
pubmed: 31617090
Ren J, Luo H, Liu S, Wang B, Wu F (2021) Short- and Mid-Term Outcomes of Transanal versus Laparoscopic Total Mesorectal Excision for Low Rectal Cancer: A Meta-Analysis. Ann Surg Treat Res 100:86. https://doi.org/10.4174/astr.2021.100.2.86
doi: 10.4174/astr.2021.100.2.86
pubmed: 33585353
pmcid: 7870425
Lei P, Ruan Y, Yang X, Fang J, Chen T (2018) Trans-Anal or Trans-Abdominal Total Mesorectal Excision? A Systematic Review and Meta-Analysis of Recent Comparative Studies on Perioperative Outcomes and Pathological Result. Int J Surg 60:113–119. https://doi.org/10.1016/j.ijsu.2018.11.003
doi: 10.1016/j.ijsu.2018.11.003
pubmed: 30415089
Ong GKb, Tsai B, Patron RL, Johansen O, Lane F, Melbert RB, Reidy T, Maun D, (2021) Transanal Total Mesorectal Excision Achieves Equivalent Oncologic Resection Compared to Laparoscopic Approach, but with Functional Consequences. Am J Surg 221:566–569. https://doi.org/10.1016/j.amjsurg.2020.11.013
doi: 10.1016/j.amjsurg.2020.11.013
Yoshimitsu K, Mori S, Tanabe K, Wada M, Hamada Y, Yasudome R, Kurahara H, Arigami T et al (2023) Transanal Total Mesorectal Excision Considering the Embryology Along the Fascia in Rectal Cancer Patients. Anticancer Res 43:3597–605. https://doi.org/10.21873/anticanres.16539
doi: 10.21873/anticanres.16539
pubmed: 37500175
Yi X, Zhang X, Li Q, Ouyang J (2023) Comparing Perioperative and Oncological Outcomes of Transanal and Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Meta-Analysis of Randomized Controlled Trials and Prospective Studies. Surg Endosc 37:9228–9243. https://doi.org/10.1007/s00464-023-10495-y
doi: 10.1007/s00464-023-10495-y
pubmed: 37872424
Sparreboom CL, Komen N, Rizopoulos D, Van Westreenen HL, Doornebosch PG, Dekker JWT, Menon AG, Tuynman JB et al (2019) Transanal Total Mesorectal Excision: How Are We Doing so Far? Colorectal Dis 21:767–774. https://doi.org/10.1111/codi.14601
doi: 10.1111/codi.14601
pubmed: 30844130
pmcid: 6850385
Xu W, Xu Z, Cheng H, Ying J, Cheng F, Xu W, Cao J, Luo J (2016) Comparison of Short-Term Clinical Outcomes between Transanal and Laparoscopic Total Mesorectal Excision for the Treatment of Mid and Low Rectal Cancer: A Meta-Analysis. Eur J Surg Oncol EJSO 42:1841–1850. https://doi.org/10.1016/j.ejso.2016.09.002
doi: 10.1016/j.ejso.2016.09.002
pubmed: 27697315
Perdawood SK, Al Khefagie GAA (2016) Transanal vs Laparoscopic Total Mesorectal Excision for Rectal Cancer: Initial Experience from Denmark. Colorectal Dis 18:51–58. https://doi.org/10.1111/codi.13225
doi: 10.1111/codi.13225
pubmed: 26603786
de’Angelis N, Portigliotti L, Azoulay D, Brunetti F, (2015) Transanal Total Mesorectal Excision for Rectal Cancer: A Single Center Experience and Systematic Review of the Literature. Langenbecks Arch Surg 400:945–959. https://doi.org/10.1007/s00423-015-1350-7
doi: 10.1007/s00423-015-1350-7
pubmed: 26497544
Ourô S, Ferreira M, Roquete P, Maio R (2022) Transanal versus Laparoscopic Total Mesorectal Excision: A Comparative Study of Long-Term Oncological Outcomes. Tech Coloproctology 26:279–290. https://doi.org/10.1007/s10151-022-02570-8
doi: 10.1007/s10151-022-02570-8
Li Z, Liu H, Luo S, Hou Y, Zhou Y, Zheng X, Zhang X, Huang L et al (2024) Long-Term Oncological Outcomes of Transanal versus Laparoscopic Total Mesorectal Excision for Mid-Low Rectal Cancer: A Retrospective Analysis of 2502 Patients. Int J Surg 110:1611–1619. https://doi.org/10.1097/JS9.0000000000000992
doi: 10.1097/JS9.0000000000000992
pubmed: 38091943
Heijden JAG, Koëter T, Smits LJH, Sietses C, Tuynman JB, Maaskant-Braat AJG, Klarenbeek BR, Wilt JHW (2020) Functional Complaints and Quality of Life after Transanal Total Mesorectal Excision: A Meta-Analysis. Br J Surg 107:489–498. https://doi.org/10.1002/bjs.11566
doi: 10.1002/bjs.11566
pubmed: 32154594
Choy KT, Yang TWW, Prabhakaran S, Heriot A, Kong JC, Warrier SK (2021) Comparing Functional Outcomes between Transanal Total Mesorectal Excision (TaTME) and Laparoscopic Total Mesorectal Excision (LaTME) for Rectal Cancer: A Systematic Review and Meta-Analysis. Int J Colorectal Dis 36:1163–1174. https://doi.org/10.1007/s00384-021-03849-2
doi: 10.1007/s00384-021-03849-2
pubmed: 33580808
Bjoern MX, Perdawood SK (2020) Manometric Assessment of Anorectal Function after Transanal Total Mesorectal Excision. Tech Coloproctology 24:231–236. https://doi.org/10.1007/s10151-020-02147-3
doi: 10.1007/s10151-020-02147-3
López-Sánchez A, Morandeira-Rivas A, Moreno-Sanz C, Cortina-Oliva FJ, Manzanera-Díaz M, Gonzales-Aguilar JD (2021) Long-Term Anorectal Manometry Outcomes After Laparoscopic and Transanal Total Mesorectal Excision. J Laparoendosc Adv Surg Tech 31:395–401. https://doi.org/10.1089/lap.2020.1005
doi: 10.1089/lap.2020.1005
McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, and the PRISMA-DTA Group, Clifford T, Cohen JF et al (2018) Preferred Reporting Items for a Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA 319:388. https://doi.org/10.1001/jama.2017.19163
doi: 10.1001/jama.2017.19163
pubmed: 29362800
Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, et al (2017). AMSTAR 2: A Critical Appraisal Tool for Systematic Reviews That Include Randomised or Non-Randomised Studies of Healthcare Interventions, or Both. BMJ: j4008. https://doi.org/10.1136/bmj.j4008 .
Brooke BS, Schwartz TA, Pawlik TM (2021) MOOSE Reporting Guidelines for Meta-Analyses of Observational Studies. JAMA Surg 156:787. https://doi.org/10.1001/jamasurg.2021.0522
doi: 10.1001/jamasurg.2021.0522
pubmed: 33825847
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan—a Web and Mobile App for Systematic Reviews. Syst Rev 5:210. https://doi.org/10.1186/s13643-016-0384-4
doi: 10.1186/s13643-016-0384-4
pubmed: 27919275
pmcid: 5139140
Emmertsen KJ, Laurberg S (2012) Low Anterior Resection Syndrome Score: Development and Validation of a Symptom-Based Scoring System for Bowel Dysfunction After Low Anterior Resection for Rectal Cancer. Ann Surg 255:922–928. https://doi.org/10.1097/SLA.0b013e31824f1c21
doi: 10.1097/SLA.0b013e31824f1c21
pubmed: 22504191
Juul T, Ahlberg M, Biondo S, Emmertsen KJ, Espin E, Jimenez LM, Matzel KE, Palmer G et al (2014) International Validation of the Low Anterior Resection Syndrome Score. Ann Surg 259:728–734. https://doi.org/10.1097/SLA.0b013e31828fac0b
doi: 10.1097/SLA.0b013e31828fac0b
pubmed: 23598379
Wadie BS, Ibrahim E-HI, De La Rosette JJ, Gomha MA, Ghoneim MA (2001) The relationship of the international prostate symptom score and objective parameters for diagnosing bladder outlet obstruction. Part i: when statistics fail. J Urol 165:32–34. https://doi.org/10.1097/00005392-200101000-00008
doi: 10.1097/00005392-200101000-00008
pubmed: 11125357
Jorge MJN, Wexner SD (1993) Etiology and Management of Fecal Incontinence. Dis Colon Rectum 36:77–97. https://doi.org/10.1007/BF02050307
doi: 10.1007/BF02050307
pubmed: 8416784
Ganesh V, Agarwal A, Popovic M, Cella D, McDonald R, Vuong S, Lam H, Rowbottom L et al (2016) Comparison of the FACT-C, EORTC QLQ-CR38, and QLQ-CR29 Quality of Life Questionnaires for Patients with Colorectal Cancer: A Literature Review. Support Care Cancer 24:3661–3668. https://doi.org/10.1007/s00520-016-3270-7
doi: 10.1007/s00520-016-3270-7
pubmed: 27193118
Sprangers MAG, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK (1998) The European Organization for Research and Treatment of Cancer Approach to Developing Questionnaire Modules: An Update and Overview. EORTC Quality of Life Study Group. Qual Life Res 7:291–300. https://doi.org/10.1023/A:1008890401133
doi: 10.1023/A:1008890401133
pubmed: 9610213
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. JNCI J Natl Cancer Inst 85:365–376. https://doi.org/10.1093/jnci/85.5.365
doi: 10.1093/jnci/85.5.365
pubmed: 8433390
Wan X, Wang W, Liu J, Tong T (2014) Estimating the Sample Mean and Standard Deviation from the Sample Size, Median, Range and/or Interquartile Range. BMC Med Res Methodol 14:135. https://doi.org/10.1186/1471-2288-14-135
doi: 10.1186/1471-2288-14-135
pubmed: 25524443
pmcid: 4383202
Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF et al (2011) The Cochrane Collaboration’s Tool for Assessing Risk of Bias in Randomised Trials. BMJ 343:d5928–d5928. https://doi.org/10.1136/bmj.d5928
doi: 10.1136/bmj.d5928
pubmed: 22008217
pmcid: 3196245
Wells, GA, Wells, G, Shea, B, Shea, B, O’Connell, D, Peterson, J, Welch, Losos, M, Tugwell, P, Ga, SW, Zello, GA, Petersen JA (2014) The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2023) Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (Updated August 2023). Cochrane. https://doi.org/10.1002/9781119536604
Bjoern MX, Nielsen S, Perdawood SK (2019) Quality of Life After Surgery for Rectal Cancer: A Comparison of Functional Outcomes After Transanal and Laparoscopic Approaches. J Gastrointest Surg 23:1623–1630. https://doi.org/10.1007/s11605-018-4057-6
doi: 10.1007/s11605-018-4057-6
pubmed: 30603861
Veltcamp Helbach M, Koedam TWA, Knol JJ, Velthuis S, Bonjer HJ, Tuynman JB, Sietses C (2019) Quality of Life after Rectal Cancer Surgery: Differences between Laparoscopic and Transanal Total Mesorectal Excision. Surg Endosc 33:79–87. https://doi.org/10.1007/s00464-018-6276-z
doi: 10.1007/s00464-018-6276-z
pubmed: 29967994
Dou R, Sun W, Luo S, Hou Y, Zhang C, Kang L (2019) Comparison of postoperative bowel function between patients undergoing transanal and laparoscopic total mesorectal excision. Zhonghua Wei Chang Wai Ke Za Zhi Chin J Gastrointest Surg 22:246–254
Seow-En I, Wu J, Tan IE-H, Zhao Y, Seah AWM, Wee IJY, Ying-Ru Ng Y, Kwong-Wei Tan E (2024) Transanal Total Mesorectal Excision With Delayed Coloanal Anastomosis (TaTME-DCAA) Versus Laparoscopic Total Mesorectal Excision (LTME) and Robotic Total Mesorectal Excision (RTME) for Low Rectal Cancer: A Propensity Score-Matched Analysis of Short-Term Outcomes, Bowel Function, and Cost. Surg Laparosc Endosc Percutan Tech 34:54–61. https://doi.org/10.1097/SLE.0000000000001247
doi: 10.1097/SLE.0000000000001247
pubmed: 37987634
Ha RK, Park SC, Park B, Park SS, Sohn DK, Chang HJ, Oh JH (2021) Comparison of Patient-Reported Quality of Life and Functional Outcomes Following Laparoscopic and Transanal Total Mesorectal Excision of Rectal Cancer. Ann Surg Treat Res 101:1. https://doi.org/10.4174/astr.2021.101.1.1
doi: 10.4174/astr.2021.101.1.1
pubmed: 34235111
pmcid: 8255580
Foo CC, Kin Ng K, Tsang JS, Siu-hung Lo O, Wei R, Yip J, Lun Law W (2020) Low Anterior Resection Syndrome After Transanal Total Mesorectal Excision: A Comparison With the Conventional Top-to-Bottom Approach. Dis Colon Rectum 63:497–503. https://doi.org/10.1097/DCR.0000000000001579
doi: 10.1097/DCR.0000000000001579
pubmed: 32015290
Mora L, Zarate A, Serra-Aracil X, Pallisera A, Serra S, Navarro-Soto S (2019) Afectación funcional y calidad de vida tras cirugía de cáncer rectal. Cir Cir 86:868. https://doi.org/10.24875/CIRU.M18000022
doi: 10.24875/CIRU.M18000022
Rubinkiewicz M, Zarzycki P, Witowski J, Pisarska M, Gajewska N, Torbicz G, Nowakowski M, Major P et al (2019) Functional Outcomes after Resections for Low Rectal Tumors: Comparison of Transanal with Laparoscopic Total Mesorectal Excision. BMC Surg 19:79. https://doi.org/10.1186/s12893-019-0550-4
doi: 10.1186/s12893-019-0550-4
pubmed: 31277628
pmcid: 6612175
Yang W-F, Chen W, He Z, Wu Z, Liu H, Li G, Li W-L (2023) Simple Transanal Total Mesorectal Resection versus Laparoscopic Transabdominal Total Mesorectal Resection for the Treatment of Low Rectal Cancer: A Single-Center Retrospective Case-Control Study. Front Surg 10:1171382. https://doi.org/10.3389/fsurg.2023.1171382
doi: 10.3389/fsurg.2023.1171382
pubmed: 37576920
pmcid: 10413134
Li Y, Bai X, Niu B, Zhou J, Qiu H, Xiao Y, Lin G (2021) A Prospective Study of Health Related Quality of Life, Bowel and Sexual Function after TaTME and Conventional Laparoscopic TME for Mid and Low Rectal Cancer. Tech Coloproctology 25:449–459. https://doi.org/10.1007/s10151-020-02397-1
doi: 10.1007/s10151-020-02397-1
Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, Moran B, Hanna GB et al (2017) Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases. Ann Surg 266:111–117. https://doi.org/10.1097/SLA.0000000000001948
doi: 10.1097/SLA.0000000000001948
pubmed: 27735827
Donovan KF, Lee KC, Ricardo A, Berger N, Bonaccorso A, Alavi K, Zaghiyan K, Pigazzi A et al (2024) Functional Outcomes After Transanal Total Mesorectal Excision (taTME) for Rectal Cancer: Results from the Phase II North American Multicenter Prospective Observational Trial. Ann Surg. https://doi.org/10.1097/SLA.0000000000006374
doi: 10.1097/SLA.0000000000006374
pubmed: 38869440
De Simone V, Persiani R, Biondi A, Litta F, Parello A, Campennì P, Orefice R, Marra A et al (2021) One-Year Evaluation of Anorectal Functionality and Quality of Life in Patients Affected by Mid-to-Low Rectal Cancer Treated with Transanal Total Mesorectal Excision. Updat Surg 73:157–164. https://doi.org/10.1007/s13304-020-00919-y
doi: 10.1007/s13304-020-00919-y
Nishizawa Y, Ito M, Saito N, Suzuki T, Sugito M, Tanaka T (2011) Male Sexual Dysfunction after Rectal Cancer Surgery. Int J Colorectal Dis 26:1541–1548. https://doi.org/10.1007/s00384-011-1247-z
doi: 10.1007/s00384-011-1247-z
pubmed: 21562743
Sartori CA, Sartori A, Vigna S, Occhipinti R, Baiocchi GL (2011) Urinary and Sexual Disorders After Laparoscopic TME for Rectal Cancer in Males. J Gastrointest Surg 15:637–643. https://doi.org/10.1007/s11605-011-1459-0
doi: 10.1007/s11605-011-1459-0
pubmed: 21327977
Pontallier A, Denost Q, Van Geluwe B, Adam J-P, Celerier B, Rullier E (2016) Potential Sexual Function Improvement by Using Transanal Mesorectal Approach for Laparoscopic Low Rectal Cancer Excision. Surg Endosc 30:4924–4933. https://doi.org/10.1007/s00464-016-4833-x
doi: 10.1007/s00464-016-4833-x
pubmed: 26944728